Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant

TP53 gene deletion is associated with poor outcomes in multiple myeloma (MM). We report the outcomes of patients with MM with and without TP53 deletion who underwent immunomodulatory drug (IMiD) and/or proteasome inhibitor (PI) induction followed by autologous hematopoietic stem cell transplant (aut...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Hematol
Autors principals: Gaballa, Sameh, Saliba, Rima M., Srour, Samer, Lu, Gary, Brammer, Jonathan E, Shah, Nina, Bashir, Qaiser, Patel, Krina, Bock, Fabian, Parmar, Simrit, Hosing, Chitra, Popat, Uday, Delgado, Ruby, Rondon, Gabriela, Shah, Jatin J., Manasanch, Elisabet E., Orlowski, Robert Z., Champlin, Richard, Qazilbash, Muzaffar
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5031524/
https://ncbi.nlm.nih.gov/pubmed/27420405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24487
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars